Showing results (411-420 of 10,436) with videos related to
Sort By:
Pageof 1,044
AIDS (London, England)|April 20, 2005
Effects of a peer-led behavioral intervention to reduce HIV transmission and promote serostatus disclosure among HIV-seropositive gay and bisexual menRichard J Wolitski, Cynthia A Gómez, Jeffrey T ParsonsAIDS (London, England)|April 20, 2005
What happened in the SUMIT trial? Mediation and behavior changeAnn O'Leary, Colleen C Hoff, David W Purcell, et al.AIDS (London, England)|September 15, 2004
Impact of HAART-related side effects on unsafe sexual behaviours in HIV-infected injecting drug users: 7-year follow upEmmanuelle Vincent, Anne-Déborah Bouhnik, Maria Patrizia Carrieri, et al.AIDS (London, England)|September 15, 2004
Decreased apoptosis of bone marrow progenitor cells in HIV-1-infected patients during highly active antiretroviral therapyAntonella Isgrò, Ivano Mezzaroma, Alessandro Aiuti, et al.AIDS (London, England)|September 15, 2004
Characterization of genotypic determinants in HR-1 and HR-2 gp41 domains in individuals with persistent HIV viraemia under T-20Anne-Geneviève Marcelin, Jacques Reynes, Sabine Yerly, et al.AIDS (London, England)|September 15, 2004
Maintenance therapy with cotrimoxazole for toxoplasmic encephalitis in the era of highly active antiretroviral therapyXavier Duval, O Pajot, V Le Moing, et al.AIDS (London, England)|September 9, 2004
Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Côte d'IvoirePatricia Fassinou, Narcisse Elenga, François Rouet, et al.AIDS (London, England)|July 29, 2004
Cost-effectiveness of nevirapine to prevent mother-to-child HIV transmission in eight African countriesMichael D Sweat, Kevin R O'Reilly, George P Schmid, et al.AIDS (London, England)|July 29, 2004
Phenotypic impact of HIV reverse transcriptase M184I/V mutations in combination with single thymidine analog mutations on nucleoside reverse transcriptase inhibitor resistanceLisa Ross, Neil Parkin, Colombe Chappey, et al.AIDS (London, England)|July 29, 2004
Differences in HIV RNA levels before the initiation of antiretroviral therapy among 1864 individuals with known HIV-1 seroconversion datesGiota Touloumi, Nikos Pantazis, Abdel G Babiker, et al.Pageof 1,044